MDRM News Alert Modern Mobility Aids (MDRM) 0.0300 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Modern Mobility Aids (MDRM) 0.0300 $MDRM

Canada's Marijuana Market: The Good, Bad, And Ugly
Matthew Finston - at Seeking Alpha - Wed Dec 31, 8:55AM CST


Modern Mobility Aids, Inc. Announces Name Change
ACCESSWIRE - Fri Dec 12, 6:46AM CST
TORONTO, ON / ACCESSWIRE / December 12, 2014 / Modern Mobility Aids, Inc. ("the Company" (OTC Pink: MDRM) announced today that the Board of Directors and shareholders approved the Company's name change to Galileo Life Sciences, Inc.

Modern Mobility Aids, Inc. Provides Update on Investments in Medical Cannabis, Innovative Health Science Products and New Marketing Initiatives
ACCESSWIRE - Mon Dec 08, 8:39AM CST
TORONTO, ON / ACCESSWIRE / December 8, 2014 / Modern Mobility Aids, Inc. (OTC Pink: MDRM) (the "Company" , announced today progress on a number of its health science and marketing and communications initiatives.

Modern Mobility Aids, Inc. Announces Formation of Medical Advisory Board
ACCESSWIRE - Tue Nov 04, 8:31AM CST
TORONTO, ON / ACCESSWIRE / November 4, 2014 / Nevada-based Modern Mobility Aids, Inc. (OTC Pink: MDRM) (the "Company" , a medical device and Biopharma company, announces that it has created a Medical Advisory Board for the Company, and in an earlier press release announced that Dr. Baseer Khan, the Company's Chief Medical Director, will serve as Chairman.

Modern Mobility Aids names Dr Baseer Khan as Chief Medical Director
M2 - Fri Sep 05, 6:27AM CDT
Modern Mobility Aids Inc (Pinksheets:MDRM), a company focused on production of medical marijuana, announced on Thursday that it has appointed Baseer U. Khan, MD, FRCS(C), as chief medical director of the company, effective immediately.

Modern Mobility Aids, Inc. Announces Appointment of Dr. Baseer Khan as Its Chief Medical Director
Marketwire - Wed Sep 03, 6:58PM CDT
Nevada-based Modern Mobility Aids, Inc. (PINKSHEETS: MDRM) (the "Company" , is pleased to announce the appointment of Baseer U. Khan, MD, FRCSCopyright, Toronto, Ontario, as Chief Medical Director of the Company effective immediately. In this role, Dr. Khan will also chair the Medical Advisory Committee of the Company. He will coordinate the medical expertise and recommendations of current board members and recruit other advisory members that reflect some of the many areas of science and medicine to which cannabis is increasingly relevant.

Modern Mobility Aids, Inc. Announces it is Now Fully Compliant With its Filing Obligations
ACCESSWIRE - Fri Aug 01, 7:11AM CDT
TORONTO, ON / ACCESSWIRE / August 1, 2014 / Nevada-based Modern Mobility Aids, Inc. (OTC Pink: MDRM) (PINKSHEETS: MDRM) (the "Company" , announced today that it has filed its Quarterly Reports for the periods ended September 30, 2013, December 31, 2013 and March 31, 2014, and that it is now fully compliant with its filing obligations to the Securities Exchange Commission. The Company expects to file the Form 10-K Annual Report for the year ended June 30, 2014, within the prescribed time period. The Company is now in position to move forward aggressively with its business plan.

Modern Mobility Aids, Inc. Announces It Is Now Fully Compliant With Its Filing Obligations
eTeligis - Fri Aug 01, 6:52AM CDT
TORONTO, ON, Canada, via ETELIGIS INC., 08/01/2014 - - Nevada-based Modern Mobility Aids, Inc. (OTC Pink: MDRM) (PINKSHEETS: MDRM) (the "Company" , announced today that it has filed its Quarterly Reports for the periods ended September 30, 2013, December 31, 2013 and March 31, 2014, and that it is now fully compliant with its filing obligations to the Securities Exchange Commission. The Company expects to file the Form 10-K Annual Report for the year ended June 30, 2014, within the prescribed time period. The Company is now in position to move forward aggressively with its business plan.

Modern Mobility to acquire 50% of Green Calyx
M2 - Thu Jul 03, 3:45AM CDT
Modern Mobility Aids Inc (Pinksheets:MDRM) (OTC Pink: MDRM), an acquirer of companies within the biopharma and alternative medicine sectors, announced on Wednesday the entering into an agreement to purchase a 50% interest in Green Calyx Inc, a flower grower based in Leamington, Ontario.

Modern Mobility Aids Announces Its Agreement to Purchase Fifty Percent of Green Calyx
Marketwire - Wed Jul 02, 8:35AM CDT
Nevada-based Modern Mobility Aids, Inc. (PINKSHEETS: MDRM) (OTC Pink: MDRM) (the "Company" , announced today that it has entered into an agreement to purchase a 50% interest in Green Calyx, Inc. part of the Newland family group of companies, a third generation flower grower in Leamington, Ontario.

Modern Mobility Aids Announces Cancellation of Over 61% of Issued and Outstanding Shares of Corporation
Marketwire - Mon Jun 30, 8:02AM CDT
Nevada-based Modern Mobility Aids, Inc. (PINKSHEETS: MDRM) (OTC Pink: MDRM) (the "Company" announced today that it has cancelled 120,000,000 shares of the corporation and reached a Major Milestone in its reorganization plan. The share certificate representing the 120 million shares is in the possession of the transfer agent for cancellation. This reduces the total share count to 75,480,000, a significant decrease in shares and a significant increase in shareholder value. The company is now positioned to execute on its expansion into the exciting Emerging Market of the Medical Marijuana space.

A Closer Look at Enertopia's Three MMJ Projects
ACCESSWIRE - Mon Jun 23, 8:40AM CDT
WHITEFISH, MT / June 23, 2014 / Canada's Marijuana for Medical Purposes Regulations ("MMPR" has attracted a lot of investor interest, as evidenced by Tweed Marijuana Inc.'s (TSX-V: TWD) (OTC: TWMJF) nearly $100 million market capitalization. Health Canada estimates that the market for legalized marijuana could surpass $1.3 billion with 450,000 patients over the next ten years, while adult use legalization could eventually add to the total.
TWD.VN: 1.950 (+0.020)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Vimi Wellness and Goodan: A Fusion of Women's Healing

Updated Category News Views 22

Crossing Continents for Women's Healing When Chelsey Goodan, an American expert in adolescent education, made her way to Hangzhou, China, it wasn't just another stop on her world tour. No, this was her first venture into China, rallying with Zhang Xinyuan, the brains behind Vimi Wellness. For those not in the know, Vimi's been pioneering women's intimate health and...

Continue Reading
UK Government Seeks Reliable Job Data Amid Survey Issues

Updated Category News Views 66

UK Government Faces Job Data Reliability Crisis The UK government has recently identified a pressing challenge in acquiring dependable jobs data essential for effective economic policy-making. This issue has arisen due to flaws in the Labor Force Survey conducted by the Office for National Statistics (ONS), which is the main instrument used to gauge the UK job market. The...

Continue Reading
HII Boosts Shareholder Confidence With New Dividend Announcement

Updated Category News Views 205

HII Announces Quarterly Cash Dividend HII (NYSE: HII) has made a significant declaration that is likely to resonate well with its shareholders. Recently, the company's Board of Directors confirmed a quarterly cash dividend of $1.35 per share to be distributed on June 13, 2025. This move underscores HII's ongoing commitment to its investors, as it rewards those holding...

Continue Reading
ZTE's Global Summit 2025: Shaping a Smarter Future in Milan

Updated Category News Views 201

ZTE's Global Summit 2025: Shaping a Smarter Future in Milan Milan recently hosted a significant event as ZTE Corporation, a renowned leader in integrated information and communication technology solutions, gathered industry leaders from around the world. Under the theme "Expanding Intelligence, Creating Possibilities," the event focused on the crucial aspects of AI-driven...

Continue Reading
Dr. Stelios Papadopoulos Joins Ovid Therapeutics' Board

Updated Category News Views 111

Dr. Stelios Papadopoulos Appointed to Ovid Therapeutics Board Ovid Therapeutics Inc. (NASDAQ: OVID), an innovative biopharmaceutical company, has made headlines with the announcement of Dr. Stelios Papadopoulos joining its Board of Directors. Known for his remarkable contributions to biotechnology, Dr. Papadopoulos brings with him a wealth of experience that promises to...

Continue Reading